TY  - CONF 
AU  - BLANCO GARCIA, FRANCISCO JAVIER
PY  - 2013
SN  - 0004-3591
UR  - http://hdl.handle.net/20.500.11940/915
LA  - eng
TI  - Long-Term (52-Week) Results Of a Phase 3, Randomized, Controlled Trial Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis and Current Skin Involvement (PALACE 3)
VL  - 65
ER  -